Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Edge Therapeut Cm S (EDGE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,868
  • Shares Outstanding, K 31,510
  • Annual Sales, $ 0 K
  • Annual Income, $ -40,870 K
  • 60-Month Beta 3.65
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.53
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.91
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/07/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.38 +32.53%
on 02/20/19
0.59 -14.63%
on 03/08/19
+0.10 (+24.35%)
since 02/15/19
3-Month
0.28 +79.86%
on 12/28/18
0.59 -14.63%
on 03/08/19
+0.07 (+15.50%)
since 12/14/18
52-Week
0.28 +79.86%
on 12/28/18
17.38 -97.10%
on 03/19/18
-14.97 (-96.74%)
since 03/15/18

Most Recent Stories

More News
Edge Technology Group Recognized as One of 2019 Tech Elite Solution Providers by CRN(R)

Edge Technology Group announced today that CRN(R), a brand of The Channel Company, has named Edge to its 2019 Tech Elite 250 list, which recognizes IT solution providers with deep...

EDGE : 0.50 (+11.42%)
PDS Biotechnology Completes Merger with Edge Therapeutics

PDS Biotechnology Corporation ("PDS Biotechnology"), a clinical-stage immuno-oncology company pioneering the development of novel multifunctional immunotherapeutic products, today announced the closing...

EDGE : 0.50 (+11.42%)
Edge Technology Group Opens Sydney Office

Edge Technology Group, a privately-owned, fully-managed IT service provider for leading financial firms worldwide, has announced its expansion into Australia. Edge opened its eighth office,...

EDGE : 0.50 (+11.42%)
Hercules Capital Reports Record Fourth Quarter and Full-Year 2018 Financial Results

--Record FY2018 New Debt and Equity Commitments of $1.21 Billion, up 37.6% Year-over-Year

MITO : 12.16 (-0.98%)
WFC : 46.17 (+1.34%)
HTGC : 13.24 (+0.08%)
HCXZ : 25.00 (-0.32%)
EDGE : 0.50 (+11.42%)
HCXY : 25.35 (+0.40%)
WMT : 102.67 (+0.80%)
Edge Therapeutics Announces Full Year 2018 Financial Results

Edge Therapeutics, Inc. (Nasdaq: EDGE) today announced financial results for the full-year ended December 31, 2018.

EDGE : 0.50 (+11.42%)
Consolidated Research: 2019 Summary Expectations for Rockwell Automation, Edge Therapeutics, Maiden, Hyster-Yale Materials Handling, Park Electrochemical, and CSW Industrials -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Rockwell Automation, Inc....

HY : 44.68 (-1.06%)
MHLD : 0.63 (+5.91%)
PKE : 16.12 (-0.37%)
EDGE : 0.50 (+11.42%)
CSWI : 63.69 (-0.59%)
ROK : 154.78 (-0.23%)
Edge Technology Group Announces Continued Organic Growth, Adding 63 New Clients in 2018

Edge Technology Group, a privately-owned fully-managed IT service provider and trusted technology advisor for leading financial firms worldwide, added 63 new clients in 2018. This brings...

EDGE : 0.50 (+11.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade EDGE with:

Business Summary

Edge Therapeutics, Inc. is a biotechnology company which discovers, develops and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product candidate which are in preclinical trial EG-1962, a polymer-based microparticle used for the treatment of aneurysmal...

See More

Key Turning Points

2nd Resistance Point 0.63
1st Resistance Point 0.57
Last Price 0.50
1st Support Level 0.44
2nd Support Level 0.38

See More

52-Week High 17.38
Fibonacci 61.8% 10.85
Fibonacci 50% 8.83
Fibonacci 38.2% 6.81
Last Price 0.50
52-Week Low 0.28

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar